Código QR (código de barras bidimensional)

Clinical Efficacy and Safety of Ivacaftor/Lumacaftor Combination in Patients with Cystic Fibrosis: International Studies Review

Cystic fibrosis is an autosomal recessive disease caused by structure abnormalities in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. It is characterized by severe course and poor prognosis without or with insufficient treatment. Approval of pathogenetic therapy medications, CF...

Fuld beskrivelse

Na minha lista:
Principais autores: Nataliya Yu. Kashirskaya, Nika V. Petrova, Rena A. Zinchenko
Format: Artigo
Sprog:Inglês
Udgivet: "Paediatrician" Publishers LLC 2021-12-01
Serier:Вопросы современной педиатрии
Fag:
cystic fibrosis
pathogenetic therapy
cftr modulators
ivacaftor
lumacaftor
Online adgang:https://vsp.spr-journal.ru/jour/article/view/2794
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker